Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 556 citations
https://doi.org/10.1016/s0140-6736(21)00149-5
N
Nausheen Ahmed
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
380
Papers
4.6K
Citations
29
h-index
68
i10-index
Nausheen Ahmed is an academic researcher from Alzaiem Alazhari University. The author has contributed to research in topics: CAR-T cell therapy research & Multiple Myeloma Research and Treatments & Hematopoietic Stem Cell Transplantation. The author has an h-index of 29, co-authored 323 publications.
ORCID: 0000-0003-4336-4982Papers by this author
worksConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · The Lancet · 516 citations
https://doi.org/10.1016/s0140-6736(21)00897-7
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · The Lancet · 320 citations
https://doi.org/10.1016/s0140-6736(22)01109-6
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 289 citations
https://doi.org/10.1016/s0140-6736(21)01825-0
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
2020 · Virology Journal · 128 citations
https://doi.org/10.1186/s12985-020-01415-w
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients
2021 · Transplantation and Cellular Therapy · 54 citations
https://doi.org/10.1016/j.jtct.2021.07.005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat